Cargando…
Barriers, solutions, and effect of using pharmacogenomics data to support opioid prescribing
Opioid use and misuse are continued issues facing clinicians across all aspects of health care. As clinicians struggle to effectively manage opioid prescribing, pharmacogenomics (PGx) further offers the prescriber an improved ability to understand the potential for an individual patient’s genetics t...
Autores principales: | Bright, David, Petry, Natasha, Roath, Eric, Reckow, Elizabeth, Chavour, Sreekanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390958/ https://www.ncbi.nlm.nih.gov/pubmed/33252002 http://dx.doi.org/10.18553/jmcp.2020.26.12.1597 |
Ejemplares similares
-
The Role of Pharmacogenomics in Opioid Prescribing
por: Wong, Aaron K., et al.
Publicado: (2022) -
Comment from the Academic Consortium for Integrative Medicine & Health on
the CDC Clinical Practice Guideline for Prescribing Opioids–United States,
2022
por: Tick, Heather, et al.
Publicado: (2022) -
Virtual reality therapy: A promising solution to chronic pain management amidst an opioid crisis
por: Ahmed, Huda, et al.
Publicado: (2023) -
Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
por: Kisor, David F, et al.
Publicado: (2021) -
The Cancer Experience Map: An Approach to Including the Patient Voice in Supportive Care Solutions
por: Hall, Leslie Kelly, et al.
Publicado: (2015)